{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:00:07Z","timestamp":1774620007979,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\u03b2 -adrenoreceptor blockers such as propranolol provoke bronchoconstriction only in asthmatic patients. Although cysteinyl leukotrienes (cLTs) and thromboxane A2 (TXA2) have been proposed to be involved in the pathophysiology of asthma, the role of these lipid mediators in propranolol-induced bronchoconstriction (PIB) has not been evaluated in asthmatics. This study was conducted to elucidate it. Nine patients with stable asthma, in whom a 20% or more decrease in FEV1 occurred by inhalation of 20 mg\/ml or less propranolol, participated in this study. A cLT antagonist, pranlukast (225 mg twice a day), a TXA2 antagonist, seratrodast (80 mg once a day), and placebo were orally given for 2 wk in a randomized and double-blinded manner. The provocative concentration of propranolol causing a 20% fall in FEV1 (PC20) was determined on the last day of each 2-wk treatment. Pranlukast, but not seratrodast, tented to increase FEV1 compared with placebo (2.14 \u00b1 0.29 versus 1.99 \u00b1 0.34 L, p = 0.0543). Pranlukast or seratrodast did not affect the PC20 in comparison with placebo. We conclude that cLTs or TXA2 are not involved in PIB of asthmatics. Fujimura M, Abo M, Kamio Y, Myou S, Ishiura Y, Hashimoto T, Matsuda T. Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction.<\/jats:p>","DOI":"10.1164\/ajrccm.160.6.9902110","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:06:08Z","timestamp":1365084368000},"page":"2100-2103","source":"Crossref","is-referenced-by-count":8,"title":["Effect of Leukotriene and Thromboxane Antagonist on Propranolol-induced Bronchoconstriction"],"prefix":"10.1093","volume":"160","author":[{"given":"MASAKI","family":"FUJIMURA","sequence":"first","affiliation":[{"name":"The Third Department of Internal Medicine and Department of Laboratory Medicine, Kanazawa University School of Medicine; The Central Laboratory, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MIKI","family":"ABO","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine and Department of Laboratory Medicine, Kanazawa University School of Medicine; The Central Laboratory, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUMIE","family":"KAMIO","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine and Department of Laboratory Medicine, Kanazawa University School of Medicine; The Central Laboratory, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHIGEHARU","family":"MYOU","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine and Department of Laboratory Medicine, Kanazawa University School of Medicine; The Central Laboratory, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIHISA","family":"ISHIURA","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine and Department of Laboratory Medicine, Kanazawa University School of Medicine; The Central Laboratory, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKUMA","family":"HASHIMOTO","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine and Department of Laboratory Medicine, Kanazawa University School of Medicine; The Central Laboratory, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAMOTSU","family":"MATSUDA","sequence":"additional","affiliation":[{"name":"The Third Department of Internal Medicine and Department of Laboratory Medicine, Kanazawa University School of Medicine; The Central Laboratory, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"2026032708522804300_B1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(64)92617-0","article-title":"Effect of beta-adrenergic-blocking agent, propranolol, on asthmatics.","volume":"11","author":"McNeill","year":"1964","journal-title":"Lancet"},{"key":"2026032708522804300_B2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/bja\/39.12.919","article-title":"The effect of propranolol on airway resistance.","volume":"39","author":"Macdonald","year":"1967","journal-title":"Br. J. Anaesth."},{"key":"2026032708522804300_B3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM196609152751103","article-title":"Bronchial response to beta-adrenergic blockade.","volume":"275","author":"Zaid","year":"1966","journal-title":"N. Engl. J. Med."},{"key":"2026032708522804300_B4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0091-6749(76)90093-2","article-title":"The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects.","volume":"57","author":"Townly","year":"1976","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032708522804300_B5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1164\/ajrccm\/139.6.1390","article-title":"Anticholinergic blockade of beta-blocker-induced bronchoconstriction.","volume":"139","author":"Ind","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708522804300_B6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(81)90154-0","article-title":"Propranolol induced bronchoconstriction: a non specific side effect of beta-adrenergic blocking therapy.","volume":"73","author":"Terpstra","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"2026032708522804300_B7","first-page":"503","article-title":"Effect of oral terfenadine on the bronchoconstrictor response to inhaled propranolol and histamine in asthmatics.","volume":"49","author":"Carpentiere","year":"1991","journal-title":"Curr. Ther. Res."},{"key":"2026032708522804300_B8","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/ajrccm.149.6.8004303","article-title":"Involvement of thromboxane A2 in propranolol-induced bronchoconstriction after allergic bronchoconstriction in guinea pigs.","volume":"149","author":"Songur","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708522804300_B9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2222.1997.tb01160.x","article-title":"Role of leukotrienes in post-allergic propranolol-induced bronchoconstriction in guinea pigs.","volume":"27","author":"Fujimura","year":"1997","journal-title":"Clin. Exp. Allergy"},{"key":"2026032708522804300_B10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0140-6736(91)90277-V","article-title":"Effect of cysteinyl leukotriene receptor antagonist ICI-204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.","volume":"337","author":"Taylor","year":"1991","journal-title":"Lancet"},{"key":"2026032708522804300_B11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0091-6749(92)90071-9","article-title":"Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.","volume":"90","author":"Rasmussen","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032708522804300_B12","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJM199012203232504","article-title":"Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene-D4 receptor antagonist.","volume":"323","author":"Manning","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"2026032708522804300_B13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/ajrccm\/140.5.1348","article-title":"Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics.","volume":"149","author":"Israel","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708522804300_B14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1164\/ajrccm.150.1.8025759","article-title":"Inhibition of analgesic- induced asthma by leukotriene receptor antagonist ONO-1078.","volume":"150","author":"Yamamoto","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708522804300_B15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/02770908809073198","article-title":"Thromboxane A2 production in allergen-induced immediate and late asthmatic responses: its possible role in inducing the late response.","volume":"25","author":"Iwamono","year":"1988","journal-title":"J. Asthma"},{"key":"2026032708522804300_B16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/02770909109073367","article-title":"Effect of OKY-046 (thromboxane A2 synthetase inhibitor) on exercise-induced asthma.","volume":"28","author":"Hoshino","year":"1991","journal-title":"J. Asthma"},{"key":"2026032708522804300_B17","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1152\/jappl.1989.66.4.1685","article-title":"Effect of thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction.","volume":"66","author":"Beasley","year":"1989","journal-title":"J. Appl. Physiol."},{"key":"2026032708522804300_B18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1378\/chest.114.4.1028","article-title":"Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma.","volume":"114","author":"Obase","year":"1998","journal-title":"Chest"},{"key":"2026032708522804300_B19","first-page":"71","article-title":"Utility of a leukotriene C4, D4 and E4 antagonist, ONO-1078, on adult bronchial asthma in multi-center comparative double-blind clinical study with azelastine hydrochloride [in Japanese].","volume":"9(Suppl.)","author":"Miyamoto","year":"1993","journal-title":"Rinsho-Iyaku"},{"key":"2026032708522804300_B20","first-page":"101","article-title":"Dose finding study of AA-2414, a thromboxane A2 receptor antagonist, in adult patients with bronchial asthma: establishment of optimal dose in multi-center double-blind comparative study [in Japanese].","volume":"9(Suppl.)","author":"Nakajima","year":"1993","journal-title":"Rinsho- Iyaku"},{"key":"2026032708522804300_B21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0952-3278(98)90061-8","article-title":"Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics.","volume":"59","author":"Aizawa","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"2026032708522804300_B22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0091-6749(91)90013-E","article-title":"Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses.","volume":"87","author":"Wenzel","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032708522804300_B23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/ajrccm\/139.2.450","article-title":"Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups: an alteration in the ratio of bronchoconstrictive to bronchoprotective mediators.","volume":"139","author":"Wenzel","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708522804300_B24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1183\/09031936.93.05020190","article-title":"Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma.","volume":"5","author":"Crea","year":"1992","journal-title":"Eur. Respir. J."},{"key":"2026032708522804300_B25","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1442","article-title":"Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679.","volume":"147","author":"Impens","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708522804300_B26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0954-6111(93)90141-L","article-title":"Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma.","volume":"87","author":"Fujimura","year":"1993","journal-title":"Respir. Med."},{"key":"2026032708522804300_B27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/pulp.1995.1034","article-title":"Involvement of thromboxane A2 in bronchial hyperresponsiveness of asthma.","volume":"8","author":"Fujimura","year":"1995","journal-title":"Pulm. Pharmacol."},{"key":"2026032708522804300_B28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0091-6749(87)90034-0","article-title":"A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity.","volume":"80","author":"Okayama","year":"1987","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/160\/6\/2100\/67430661\/ajrccm_160_6_2100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/160\/6\/2100\/67430661\/ajrccm_160_6_2100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:53:21Z","timestamp":1774616001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/160\/6\/2100\/8529651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12,1]]},"published-print":{"date-parts":[[1999,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.160.6.9902110","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,12]]},"published":{"date-parts":[[1999,12,1]]}}}